¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed type of artery"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • coronary artery
    °ü»óµ¿¸Æ, ½ÉÀ嵿¸Æ
  • coronary artery bypass
    °ü»óµ¿¸Æ¿ìȸ·Î, ½ÉÀ嵿¸ÆµÎ¸§±æ
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ¼ú, ½ÉÀ嵿¸Æ¿ìȸ¼ú
  • coronary artery bypass surgery
    °ü»óµ¿¸Æ¿ìȸ·ÎÁ¶¼º¼ú, ½ÉÀ嵿¸Æ¿ìȸ·ÎÁ¶¼º¼ú
  • coronary artery disease
    °ü»óµ¿¸Æº´, ½ÉÀ嵿¸Æº´
  • calcaneal artery fasciocutaneous flap
    ¹ß²ÞÄ¡µ¿¸Æ±Ù¸·ÇÇÆÇ, Á¾°ñµ¿¸Æ±Ù¸·ÇÇÆÇ
  • cremasteric artery
    °íȯ¿Ã¸²±Ùµ¿¸Æ, °íȯ°Å±Ùµ¿¸Æ
  • cystic artery
    ¾µ°³µ¿¸Æ, ´ã³¶µ¿¸Æ
  • carotid artery
    ¸ñµ¿¸Æ, °æµ¿¸Æ
  • cecal artery
    ¸·Ã¢ÀÚµ¿¸Æ, ¸ÍÀ嵿¸Æ
  • celiac artery
    º¹°­µ¿¸Æ
  • central artery
    Á߽ɵ¿¸Æ
  • central retinal artery
    ¸Á¸·Á߽ɵ¿¸Æ
  • cerebral artery
    ´ë³úµ¿¸Æ
  • callosomarginal artery
    ³úµéº¸ÁÖº¯µ¿¸Æ, ³ú·®º¯¿¬µ¿¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • carotid artery
    ¸ñµ¿¸Æ
  • cecal artery
    ¸·Ã¢ÀÚµ¿¸Æ
  • celiac artery
    º¹°­µ¿¸Æ
  • central artery
    Á߽ɵ¿¸Æ
  • central retinal artery
    ¸Á¸·Á߽ɵ¿¸Æ
  • cerebral artery
    ´ë³úµ¿¸Æ
  • choroidal artery
    ¸Æ¶ô¸·µ¿¸Æ
  • ciliary artery
    ¼¶¸ðüµ¿¸Æ
  • circumflex femoral artery
    ³Ò´Ù¸®ÈÖµ¹À̵¿¸Æ
  • circumflex humeral artery
    À§ÆÈÈÖµ¹À̵¿¸Æ
  • circumflex iliac artery
    ¾ûµ¢ÈÖµ¹À̵¿¸Æ
  • circumflex scapular artery
    ¾î±úÈÖµ¹À̵¿¸Æ
  • colic artery
    Àß·èâÀÚµ¿¸Æ
  • common carotid artery
    ¿Â¸ñµ¿¸Æ
  • common hepatic artery
    ¿Â°£µ¿¸Æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • anterior superior pancreaticoduodenal artery
    ¾ÕÀ§ÀÌÀÚ»ùâÀÚµ¿¸Æ
  • anterior temporal artery
    ¾Õ°üÀÚ¿±µ¿¸Æ
  • anterior tibial artery
    Àü¹æ °æ°ñ µ¿¸Æ(îñÛ°ÌëÍéÔÑØæ), Àü °æ°ñ µ¿¸Æ(îñÌëÍéÔÑØæ).
  • anterior tibial artery
    ¾ÕÁ¤°­µ¿¸Æ
  • anterior tibial recurrent artery
    Àü¹æ °æ°ñ ȸ±Í µ¿¸Æ(îñÛ°ÌëÍéüÞÏýÔÑØæ), Àü °æ°ñ ¹Ýȸ µ¿¸Æ(¡­ÍéÚãüÞÔÑØæ).
  • anterior tibial recurrent artery
    ¾ÕÁ¤°­µÇµ¹À̵¿¸Æ
  • anterior tympanic artery
    ¾Õ°í½Çµ¿¸Æ
  • appendicular artery
    ¸·Ã¢ÀÚ²¿¸®µ¿¸Æ
  • appendicular artery<³ª> arteria appendicularis
    Ãæ¼öµ¿¸Æ(Ãæ¼öµ¿¸Æ).
  • arcuate artery
    ±Ã»óµ¿¸Æ(ÏáßÒÔÑØæ)
  • arcuate artery
    (Ȱ²Ãµ¿¸Æ)
  • arcuate artery
    Ȱ¸ð¾çµ¿¸Æ(¡­Ù¼åÆÔÑØæ)
  • arcuate artery
    ±Ã»óµ¿¸Æ
  • arcuate artery
    Ȱ²Ãµ¿¸Æ
  • artery
    Á¤Çü¹æ»ç ¸¶Ãë,»ý¸®,¿Ü°ú,»êºÎ,ºñ´¢µ¿¸Æ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • mixed leukemia
    È¥ÇÕ¼º ¹éÇ÷º´(?ËÑÌ´ËÓ).
  • mixed liquor
    È¥ÇÕ¾×(ûèùêäû).
  • mixed lymphocytc culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç
  • mixed lymphocyte culture
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç(̴̰?Ë´ËÑËâ).
  • mixed lymphocyte culture
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç(¡­ûèùêÏ¹ÛÆå×).
  • mixed lymphocyte culture(MLC)
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸ È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed lymphocyte response(MLR)
  • mixed lymphocytic large cell lymphoma
    È¥ÇÕ ´ë¸²ÇÁ±¸¼º¸²ÇÁÁ¾
  • mixed lymphohistiocytic lymphoma
    È¥ÇÕ ¸²ÇÁÁ¶Á÷±¸¼º¸²ÇÁÁ¾
  • mixed melting point
    È¥À¶Á¡(ûèë×ïÇ).
  • mixed mesodermal tumor
    È¥ÇÕ Á߹迱¼º Á¾¾ç
  • mixed mesodermal tumor
    È¥ÇÕ¼º Á߹迱¼º Á¾¾ç(¡­ ñéÛÏç¨àõ ðþåË)
  • mixed mullerian sarcoma
    È¥ÇÕ ¹Á·¯¸®¾È À°Á¾
  • mixed mullerian tumor
    È¥ÇÕ¼º ¹Á·¯ Á¾¾ç, È¥ÇÕ¼º Muller Á¾¾ç(ûèùêàõ ¡­ ðþåË)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Posterior inferior cerebellar artery
    µÚ¾Æ·¡¼Ò³úµ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄÇϼҳúµ¿¸Æ
  • Posterior gastric artery
    µÚÀ§µ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄÀ§µ¿¸Æ
  • Posterior superior pancreaticoduodenal artery
    µÚÀ§ÀÌÀÚ»ùâÀÚµ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄ»óÃé½ÊÀÌÁöÀ嵿¸Æ
  • Posterior superior alveolar artery
    µÚÀ§ÀÌÆ²µ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄ»óÄ¡Á¶µ¿¸Æ
  • Posterior circumflex humeral artery
    µÚÀ§ÆÈÈÖµ¹À̵¿¸Æ
    [¿¾ ¿ë¾î] ÈÄ»ó¿Ïȸ¼±µ¿¸Æ
  • Dorsal pancreatic artery
    µÚÀÌÀÚµ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄÃ鵿¸Æ
  • Posterior tibial artery
    µÚÁ¤°­µ¿¸Æ
    [¿¾ ¿ë¾î] Èİæ°ñµ¿¸Æ
  • Posterior spinal artery
    µÚô¼öµ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄô¼öµ¿¸Æ
  • Occipital artery
    µÚÅë¼öµ¿¸Æ
    [¿¾ ¿ë¾î] Èĵε¿¸Æ
  • Groove for occipital artery
    µÚÅë¼öµ¿¸Æ°í¶û
    [¿¾ ¿ë¾î] Èĵε¿¸Æ±¸
  • Dorsal intersegmental artery
    µîÂʸ¶µð»çÀ̵¿¸Æ
    [¿¾ ¿ë¾î] ¹èÀý°£µ¿¸Æ
  • Artery of lymph nodule
    ¸²ÇÁ¼ÒÀýµ¿¸Æ
    [¿¾ ¿ë¾î] ÀӯļÒÀýµ¿¸Æ
  • Parietooccipital artery
    ¸¶·çµÚÅë¼ö¿±µ¿¸Æ
    [¿¾ ¿ë¾î] µÎÁ¤Èĵε¿¸Æ
  • Appendicular artery
    ¸·Ã¢ÀÚ²¿¸®µ¿¸Æ
    [¿¾ ¿ë¾î] Ãæ¼öµ¿¸Æ
  • Central artery of retina
    ¸Á¸·Á߽ɵ¿¸Æ
    [¿¾ ¿ë¾î] ¸Á¸·Á߽ɵ¿¸Æ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • ulnar artery
    ô°ñµ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
SCA self-care agency; severe congenital anomaly; sickle-cell anemia; single-camera autostereoscopic [ima...
SOA-MCA superficial occipital artery to middle cerebral artery
STA-MCA superficial temporal artery to middle cerebral artery
DMH Daily Mixed Headache
DMLH Diffuse Mixed Lymphocytic Histiocytic
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
MECLR mixed epidermal cell - T lymphocyte reaction
MFO mixed function oxidase system
MLR mixed leucocyte response
MLTC mixed leukocyte tumor cell culture
(MLR mixed lymphocyte culture
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anterior spinal artery syndrome
    Àüô¼ö µ¿¸Æ ÁõÈıº
  • arcuate artery
    ±Ã»ó µ¿¸Æ
  • artery
    µ¿¸Æ
    ½ÉÀå¿¡¼­ ½ÅüÀÇ ¿©·¯ ºÎºÐÀ¸·Î Ç÷¾×À» ¿î¹ÝÇÏ´Â Ç÷°ü.
  • auditory artery
    ûµ¿¸Æ
  • basilar artery migraine
    ³úÀú µ¿¸Æ ÆíµÎÅë
  • bronchial artery
    ±â°üÁö µ¿¸Æ
  • buccal artery
    º¼µ¿¸Æ, Çùµ¿¸Æ
  • callosomarginal artery
    ³ú µéº¸ ÁÖº¯ µ¿¸Æ
  • capsular artery
    ÇǸ· µ¿¸Æ
  • carotid artery
    °æµ¿¸Æ, ¸ñµ¿¸Æ
    °æºÎ, ¾È¸é, µÎ°³°ñ, ³ú, ÁßÀÌ, ³úÇϼöü, ¾È±¸, Ãø¹æ ³ú½ÇÀÇ ¸Æ¶ô¸· ÃÑ
  • carotid artery syndrome
    °æµ¿¸Æ ÁõÈıº
  • caudal pancreatic artery
    ÀÌÀÚ ²¿¸® µ¿¸Æ, Ãé¹Ì µ¿¸Æ
  • central artery cerebri mediae
    ÁߺΠ³úµ¿¸Æ Áß½ÉÁö
  • central artery of retina
    ¸Á¸· Á᫐ µ¿¸Æ
  • central retinal artery
    ¸Á¸· Á᫐ µ¿¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
mpgn type II A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure. Membranoproliferative glomerulonephritis (MPGN) has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
(27 Sep 1997)
woodbury-type 1. A process in photographic printing, in which a relief pattern in gelatin, which has been hardened after certain operations, is pressed upon a plate of lead or other soft metal. An intaglio impression in thus produced, from which pictures may be directly printed, but by a slower process than in common printing.
2. A print from such a plate.
Origin: After the name of the inventor, W. Woodbury.
Source: Websters Dictionary
(01 Mar 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
multiple lipoprotein-type hyperlipidaemia <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease.
Origin: Gr. Haima = blood
(27 Sep 1997)
contact-type dermatitis Dermatitis resembling contact dermatitis or eczema, but caused by an ingested or injected allergen, usually a drug, and with a widespread or generalised distribution.
(05 Mar 2000)
Cowdry's type A inclusion bodies Droplet-like masses of acidophilic material surrounded by clear halos within nuclei, with margination of chromatin on the nuclear membrane.
(05 Mar 2000)
Cowdry's type B inclusion bodies Droplet-like masses of acidophilic material surrounded by clear halos within nuclei, without other nuclear changes during early stages of development of the inclusion.
(05 Mar 2000)
habitat type <ecology> A land or aquatic unit, consisting of an aggregation of habitats having equivalent structure, function, and responses to disturbance.
(09 Oct 1997)
haemadsorption virus type 1 parainfluenza virus type 3
haemadsorption virus type 2 parainfluenza virus type 1
C type lectin <cell biology> One of two classes of lectin produced by animal cells, the other being the S type.
The C type lectins require disulphide linked cysteines and Ca ions in order to bind to a specific carbohydrate (c.f. S type lectins). The carbohydrate recognition domain of C type lectins consists of about 130 amino acids which contains 18 invariant residues in a highly conserved pattern.
These invariant residues include cysteines which probably form disulphide bonds. So far, all identified C type lectins are extracellular proteins and include both Integral membrane proteins, such as the asialoglycoprotein receptor and soluble proteins.
(06 Aug 1998)
C type virus <molecular biology, virology> Originally C type particles identified in mouse tumour tissue and later shown to be oncogenic RNA viruses Oncovirinae) that bud from the plasma membrane of the host cell starting as a characteristic electron dense crescent.
Include feline leukaemia virus, murine leukaemia and sarcoma viruses.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á